Apellis Pharmaceuticals Inc logo

Apellis Pharmaceuticals Inc

1
NAS:APLS (USA)  
$ 70.18 +1.71 (+2.5%) 11:35 AM EST
At Loss
P/B:
34.92
Volume:
470.76K
Avg Vol (2M):
1.64M
Also Trade In:
Volume:
470.76K
At Loss
Avg Vol (2M):
1.64M

Business Description

Apellis Pharmaceuticals Inc logo
Apellis Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US03753U1060
Description
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.
Name Current Vs Industry Vs History
Cash-To-Debt 4.13
Equity-to-Asset 0.28
Debt-to-Equity 0.47
Debt-to-EBITDA -0.19
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.51
Distress
Grey
Safe
Beneish M-Score 6.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.11
9-Day RSI 57.71
14-Day RSI 56.51
6-1 Month Momentum % 65.28
12-1 Month Momentum % -1.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.29
Quick Ratio 3.76
Cash Ratio 2.44
Days Inventory 760.73
Days Sales Outstanding 87.61
Days Payable 226.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.1
Shareholder Yield % -3.81

Financials (Next Earnings Date:2024-02-27)

APLS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APLS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Apellis Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 272.877
EPS (TTM) ($) -5.25
Beta 0.09
Volatility % 109.09
14-Day RSI 56.51
14-Day ATR ($) 2.342913
20-Day SMA ($) 66.773
12-1 Month Momentum % -1.16
52-Week Range ($) 19.8301 - 94.75
Shares Outstanding (Mil) 118.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Apellis Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Apellis Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Apellis Pharmaceuticals Inc Frequently Asked Questions

What is Apellis Pharmaceuticals Inc(APLS)'s stock price today?
The current price of APLS is $70.18. The 52 week high of APLS is $94.75 and 52 week low is $19.83.
When is next earnings date of Apellis Pharmaceuticals Inc(APLS)?
The next earnings date of Apellis Pharmaceuticals Inc(APLS) is 2024-02-27.
Does Apellis Pharmaceuticals Inc(APLS) pay dividends? If so, how much?
Apellis Pharmaceuticals Inc(APLS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1